| Brand name |
Empaveli
|
|---|---|
| المخاطر |
Risk of: 1. serious infection due to encapsulated bacteria 2. Serious hypersensitivity reactions 3. Risk of potential long-term effects of Polyethylene Glycol (PEG) accumulation 4. Risk of intravascular haemolysis after discontinuation and postponement of administration of the medicinal product (PNH indication only) 5.And to include recently Saudi approved indication C3G indication for Pegcetacoplan on updated aRMMs. |
| تاريخ الموافقة |
|
| Last updated date |
|
| Educational materials for healthcare practitioners | |
| المواد التعليمية الموجهة للمريض |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Government websites use the protocol. HTTPS for encryption and security.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.